亚太肥胖治疗市场规模、趋势、增长报告 2032

Q: 《亞太肥胖治療市場》报告涵盖的主要细分市场是什么？

市场是基于 亞太地區肥胖治療市場細分，按治療類型（藥物治療（抗肥胖藥物）、減肥手術、行為與生活方式療法、非侵入性/內視鏡手術以及醫療器械與技術）、年齡組（成人肥胖治療、老年肥胖治療和兒童肥胖治療）、分銷渠道（在線藥房、零售藥店、體重管理診所、醫院藥房和健康與健身中心）、患者類型 2020 2023 階段 -II 20 II 類 进行细分的。

Asia Pacific Obesity Treatment Market

市场规模（十亿美元）

CAGR : 16.00 %

USD 5.09 Million USD 16.72 Million 2024 2032

Forecast Period	2025 –2032
Market Size (Base Year)	USD 5.09 Million
Market Size (Forecast Year)	USD 16.72 Million
CAGR	16.00 %
Major Markets Players	Boston Scientific Corporation (U.S.) Johnson & Johnson Services Inc. (U.S.) Altimmune (U.S.) AstraZeneca (UK) Allurion (U.S.)

亞太地區肥胖治療市場細分，按治療類型（藥物治療（抗肥胖藥物）、減肥手術、行為與生活方式療法、非侵入性/內視鏡手術以及醫療器械與技術）、年齡組（成人肥胖治療、老年肥胖治療和兒童肥胖治療）、分銷渠道（在線藥房、零售藥店、體重管理診所、醫院藥房和健康與健身中心）、患者類型 2020 2023 階段 -II 20 II 類

亞太肥胖治療市場規模

2024 年亞太肥胖治療市場價值為509 萬美元，預計到 2032 年將達到 1,672 萬美元
在 2025 年至 2032 年的預測期內，市場可能會以16.0% 的複合年增長率成長，主要原因是肥胖症盛行率的上升
這一增長得益於抗肥胖藥物的創新、減重和代謝手術的成長等因素。此外，數位健康解決方案在肥胖治療中的整合也帶來了新的成長。

亞太肥胖症治療市場分析

肥胖是一種慢性疾病，其特徵是脂肪過度堆積，會增加心血管疾病、2 型糖尿病、高血壓和某些癌症等嚴重健康併發症的風險
治療方案包括生活方式改變、藥物治療、醫療器材以及減肥手術，旨在實現可持續的減肥效果並改善整體健康狀況
亞太地區肥胖治療市場的發展受到久坐不動的生活方式、不健康的飲食習慣和遺傳因素導致的肥胖盛行率上升的推動。 GLP-1受體激動劑和食慾抑制劑等藥物幹預措施在體重管理中發揮至關重要的作用，此外，行為療法和生活方式的改變也發揮著重要作用。胃繞道手術和袖狀胃切除術等減重手術也越來越受到關注，成為治療嚴重肥胖的有效長期解決方案。
對微創手術和創新減肥藥物的需求不斷增長，進一步推動了市場成長
北美仍然是亞太肥胖治療市場的主導地區，得益於完善的醫療基礎設施、高肥胖率以及對體重管理解決方案的持續研究

例如，美國在 GLP-1 受體激動劑（如索馬魯肽和利拉魯肽）的應用方面處於領先地位，並且在減肥的非侵入性醫療設備方面也取得了進展

隨著對肥胖管理和預防性醫療保健的日益重視，亞太市場正在對新療法、醫療技術和以患者為中心的解決方案進行大量投資，推動整個行業的擴張

報告範圍和肥胖治療市場細分

屬性	亞太肥胖治療市場關鍵市場洞察
涵蓋的領域	依治療類型分類- 藥物治療（抗肥胖藥物）、減重手術、行為與生活型態療法、非侵入性/內視鏡手術及醫療器材與技術依年齡層- 成人肥胖治療、老年肥胖治療及兒童肥胖治療按分銷管道- 網路藥局、零售藥局、體重管理診所、醫院藥局和健康與健身中心。依患者類型- III 類、II 類和 I 類
覆蓋國家	亞太地區中國日本印度澳洲韓國新加坡泰國菲律賓馬來西亞印尼越南台灣亞太其他地區
主要市場參與者	諾和諾德公司（丹麥）禮來公司（美國）美敦力（美國）波士頓科學公司（美國）強生服務公司（美國） Altimmune（美國）阿斯特捷利康（英國） Allurion（美國）安進公司（美國） Arena Pharmaceuticals Ltd（美國） Currax pharmaceuticals LLC（美國） COUSIN SURGERY（法國） F. Hoffmann-La Roche Ltd（瑞士） Fitterfly Healthtech Pvt. Ltd.（印度） Morphic Medical, Inc（美國） Noom, Inc.（美國） Omada Health Inc（美國） Reshape Lifesciences Inc.（美國）拉齊爾（以色列） Spatz FGIA Inc.（美國）賽諾菲（法國）薩尼奧納（丹麥） USGI醫療（美國） VIVUS LLC.（美國） Viking Therapeutics（美國）
市場機會	生活方式相關疾病的盛行率不斷上升可支配所得的增加增強了肥胖治療相關產品的購買力
加值資料資訊集	除了對市場價值、成長率、細分、地理覆蓋範圍和主要參與者等市場情景的洞察之外，Data Bridge Market Research 策劃的市場報告還包括進出口分析、生產能力概覽、生產消費分析、價格趨勢分析、氣候變遷情景、供應鏈分析、價值鏈分析、原材料/消耗品概覽、供應商選擇標準、PESTLE 分析、波特分析和監管框架。

亞太肥胖症治療市場趨勢

數位化和人工智慧驅動的體重管理解決方案的採用率不斷上升

全球肥胖治療市場的一個主要趨勢是越來越多地採用數位化和人工智慧驅動的體重管理解決方案
這些創新技術透過提供個人化治療計劃、即時監控和數據驅動的洞察來優化減肥策略，從而增強肥胖管理
- 例如，人工智慧行動應用程式和穿戴式裝置可以追蹤身體活動、卡路里攝取量和代謝率，提供客製化建議以提高依從性和效果
遠距醫療平台和虛擬指導透過提供遠距諮詢、行為諮詢和藥物管理為患者提供進一步的支持，從而實現更有效、更永續的減肥
這一趨勢正在透過提高患者參與度、增強長期治療成功率以及推動肥胖治療市場對數位健康解決方案的需求，徹底改變肥胖護理。

亞太肥胖症治療市場動態

司機

肥胖盛行率不斷上升

由於久坐的生活方式、不良的飲食習慣和遺傳傾向，肥胖流行病正在加劇，導致與肥胖相關的健康併發症（如糖尿病、心血管疾病和高血壓）急劇增加
城市化和技術進步導致體力活動減少，而加工食品和高熱量食品的廣泛消費進一步加劇了體重增加
遺傳因素也起著重要作用，許多人容易患上導致肥胖的代謝紊亂。隨著肥胖率持續飆升，對有效治療方案的需求正在顯著增長，包括藥物治療、減肥手術和醫學監督下的體重管理計劃。

例如

根據世界衛生組織 (WHO) 提供的數據，2024 年 3 月，歐洲肥胖疫情正在加劇，2022 年每 8 人中就有 1 人患有肥胖症。自 1990 年以來，成人肥胖率翻了一番，青少年肥胖率翻了兩番。超過 25 億成年人超重，其中 8.9 億人患有肥胖症。肥胖率上升導致糖尿病、心臟病和癌症的風險增加，從而刺激了對有效治療方法的需求，並推動了市場成長。
美國疾病管制與預防中心 (CDC) 指出，截至 2024 年 9 月，2021 年 8 月至 2023 年 8 月期間，40.3% 的成年人患有肥胖症，其中男性肥胖率為 39.2%，女性肥胖率為 41.3%。 40-59 歲年齡層的成年人患病率最高（46.4%），其次是 20-39 歲年齡層（35.5%）和 60 歲以上年齡層（38.9%）。預計日益加重的肥胖負擔將推動對有效肥胖治療的需求。
根據《世界肥胖地圖集》2024年的數據，到2035年，79%的超重和肥胖成年人以及88%的超重和肥胖兒童將居住在中低收入國家（LMIC）。預計肥胖成年人的數量將從2020年的8.1億增加到2035年的15.3億。肥胖盛行率的上升正在增加對肥胖治療解決方案的需求，從而推動市場成長。
日益加重的患者負擔促使醫療保健提供者、製藥公司和健康計畫擴大其服務範圍，使肥胖盛行率的上升成為歐洲肥胖治療市場的主要驅動力

機會

生活方式相關疾病的盛行率不斷上升

隨著越來越多的人尋求控制體重並減輕相關的健康風險，製藥公司和醫療保健提供者受到激勵去創新和擴大其產品範圍
這一趨勢促進了針對不同患者需求的新藥物、手術方案和綜合生活方式計劃的開發

例如

2023 年 5 月，NCBI 表示，預計到 2030 年，全球將有超過 10 億人患有肥胖症。肥胖相關死亡率和合併症（如糖尿病、心血管疾病、慢性腎臟病和幾種癌症）的發生率同樣高得驚人，平均每年造成 500 萬人死亡，傷殘調整生命年為 1.6 億年
2023年6月，根據《中國藥學報B》發表的一篇文章，肥胖是導致癌症、心血管疾病、第2型糖尿病、肝病和其他疾病的重要因素
2021年4月，美國心臟協會期刊發表的一篇文章指出，肥胖直接導致心血管危險因子的發生，包括血脂異常、第2型糖尿病、高血壓和睡眠障礙。肥胖也會導致心血管疾病的發生和心血管疾病死亡，且獨立於其他心血管危險因子。
2023 年 4 月，MoneyControl 的一項研究表明，印度的生活方式疾病數量激增，包括肥胖和膽固醇異常等早期風險因素的盛行率上升

此外，人們對肥胖健康後果的認知不斷提高，促使消費者積極主動地進行健康管理。在各國政府和衛生組織大力倡導健康生活方式的推動下，肥胖治療市場可望大幅成長。
這一勢頭吸引了投資並推動了研發工作，為廣泛的治療幹預措施鋪平了道路，以滿足不斷增長的患者群體的需求

克制/挑戰

與肥胖治療相關的長期隨訪

與肥胖治療相關的長期追蹤主要是由於此類計劃的複雜性和資源密集性，通常需要持續的監測和支持，以確保持續的體重減輕和管理，其中可以包括定期諮詢、營養指導和行為療法
這些長期承諾給醫療保健系統帶來了負擔，並給患者和醫療服務提供者帶來了後勤挑戰，導致護理方面的潛在差距和治療依從性的不一致

例如

2022年12月，根據AJMC的說法，管理肥胖需要病人和知情的臨床醫生持續的合作。管理肥胖需要患者和知情的臨床醫生持續的合作。
2022年9月，《美國醫學會雜誌》(JAMA Network) 報道，一項針對175名患者的研究顯示，3個月後，94名（53.7%）患者的體重減輕至少5%，26名（14.9%）患者的體重減輕至少10%。在102名接受6個月追蹤的患者中，89名（87.3%）患者的體重減輕至少5%，56名（54.9%）患者的體重減輕至少10%，24名（23.5%）患者的體重減輕至少15%，8名（7.8%）患者的體重減輕至少20%。
2021年11月，美國國家醫學圖書館發表的一篇文章指出，確保長期追蹤對減重患者至關重要。低品質的追蹤被認為是減重手術療效不佳的風險因素，但追蹤的多樣性和有效性也是臨床研究的決定因素。

此外，長期追蹤的必要性也阻礙了患者尋求治療。許多潛在患者可能擔心定期復診和監測所帶來的持續投入和費用，認為這些措施令人望而生畏或不便。
這種猶豫阻礙了市場成長，因為潛在消費者會迴避需要持續參與和問責的項目
因此，促進有效的長期追蹤的挑戰可能會限制肥胖治療的整體有效性及其在目標族群中的接受度

亞太肥胖治療市場範圍

市場根據類型、產品類型、吸收部位、年齡層、來源、交付方式、性別和分銷管道進行細分。

分割	細分
治療類型	藥物治療（抗肥胖藥物） GLP-1受體激動劑 GIP/GLP-1受體雙激動劑中樞作用厭食藥芬特明芬特明-托吡酯納曲酮-安非他酮脂肪酶抑制劑脫氧膽酸其他的減重手術按類型限制性手術袖狀胃切除術可調式胃束帶手術聯合手術 Roux-en-Y胃繞道手術（RYGB）微創胃繞道手術（MGB）吸收不良手術依方法腹腔鏡手術機器人輔助手術開放性手術行為與生活方式療法飲食幹預行為矯正療法體力活動計劃心理諮商非侵入性/內視鏡手術內視鏡袖狀胃成形術（ESG）胃內水球（IGB） Orbera胃內球囊 Spatz 可調氣球系統抽吸療法（AspireAssist）經口胃成形術（TOGA）醫療設備與技術人工智慧和數位體重管理平台胃電刺激裝置（Maestro 系統）
年齡組	成人肥胖症治療老年肥胖症治療兒童肥胖症治療
分銷通路-	網路藥局零售藥局體重管理診所醫院藥房健康與健身中心
患者類型	III 類 II 類 I類

亞太肥胖治療市場區域分析

中國是1型和2型糖尿病胰島素市場的主導地區

中國引領亞太肥胖治療市場，這得益於其高肥胖盛行率、先進的醫療基礎設施以及創新體重管理解決方案的廣泛採用
由於對 GLP-1 受體激動劑、減肥手術和數位體重管理平台等藥物治療的需求不斷增長，中國佔據了相當大的市場份額
此外，人們對肥胖相關健康風險的認識不斷提高，以及人工智慧減肥計劃、遠距醫療諮詢和非侵入性治療解決方案的日益普及，繼續推動該地區的市場擴張

印度預計將實現最高成長率

印度地區預計將見證亞太肥胖治療市場的最高增長率，這得益於肥胖患病率的上升、醫療保健投資的增加以及對體重管理解決方案的認識的提高
由於生活方式的轉變、城市化進程的加快以及肥胖相關健康併發症的增多，印度、中國和印尼等國家正在成為主要市場
印度醫療基礎設施不斷完善，醫療減肥治療需求不斷增長，仍然是肥胖管理的關鍵市場。該國正在見證藥物治療、減肥手術和數位化體重管理方案的普及。

亞太肥胖症治療市佔率

市場競爭格局按競爭對手提供詳細資料。詳細資訊包括公司概況、公司財務狀況、收入、市場潛力、研發投入、新市場計劃、亞太地區業務、生產基地和設施、生產能力、公司優勢和劣勢、產品發布、產品寬度和廣度以及應用主導地位。以上提供的數據點僅與公司在市場中的重點相關。

市場中主要的市場領導者有：

諾和諾德公司（丹麥）
禮來公司（美國）
美敦力（美國）
波士頓科學公司（美國）
強生服務公司（美國）
Altimmune（美國）
阿斯特捷利康（英國）
Allurion（美國）
安進公司（美國）
Arena Pharmaceuticals Ltd（美國）
Currax pharmaceuticals LLC（美國）
COUSIN SURGERY（法國）
F. Hoffmann-La Roche Ltd（瑞士）
Fitterfly Healthtech Pvt. Ltd.（印度）
Morphic Medical, Inc（美國）
Noom, Inc.（美國）
Omada Health Inc（美國）
Reshape Lifesciences Inc.（美國）
拉齊爾（以色列）
Spatz FGIA Inc.（美國）
賽諾菲（法國）
薩尼奧納（丹麥）
USGI醫療（美國）
VIVUS LLC.（美國）
Viking Therapeutics（美國）

亞太肥胖治療市場的最新發展

2024年10月，VIVUS和UpScriptHealth推出了ChooseQ. online，這是一個遠距醫療平台，方便患者便捷地使用QSYMIA進行體重管理。該服務允許患者在線諮詢醫療保健提供者，並直接在家中接受QSYMIA。該計劃旨在透過遠距醫療提高肥胖治療的可近性。
2024年10月，Zealand Pharma宣布勃林格殷格翰的Survodutide (BI 456906)獲得美國FDA突破性療法認定，用於治療伴有中度或晚期纖維化的非肝硬化代謝功能障礙相關脂肪性肝炎(MASH)。此認定因其II期臨床試驗結果良好，將加速其研發進程。
2025年3月，Zealand Pharma宣布，長效胰淀素類似物Petrelintide的2b期ZUPREME-1試驗已完成受試者招募。 Petrelintide旨在治療超重和肥胖。該試驗將在42週內評估不同劑量Petrelintide對體重、安全性和耐受性的影響，預計結果將於2025年公佈。
2025年3月，專注於醫療美容市場新一代處方藥的製藥公司Raziel Therapeutics宣佈在中國啟動RZL-012的第三期臨床研究，旨在減少頦下脂肪（SMF）。減少SMF是RZL-012的首個適應症，在塑身美容減脂治療中具有潛在應用。
2022年10月，減重和代謝健康解決方案領域的領導者ReShape Lifesciences宣布，美國代謝和減肥手術學會(ASMBS)和國際肥胖和代謝紊亂外科聯合會(IFSO)發布了最新的代謝和減肥手術指南，其中現已涵蓋Lap-Band腹帶手術。這些指南將取代美國國立衛生研究院(NIH)於1991年制定的已有30年歷史的標準。

SKU-73840

Get online access to the report on the World's First Market Intelligence Cloud

Click on image to enlarge

Interactive Data Analysis Dashboard
Company Analysis Dashboard for high growth potential opportunities
Research Analyst Access for customization & queries
Competitor Analysis with Interactive dashboard
Latest News, Updates & Trend analysis
Harness the Power of Benchmark Analysis for Comprehensive Competitor Tracking

Request for Demo

表格列表

TABLE 1 OBESITY PREVALENCE BY REGION (ADULTS)

TABLE 2 OBESITY PREVALENCE BY GENDER (ADULTS)

TABLE 3 OBESITY PREVALENCE BY AGE (ADULTS)

TABLE 4 ASIA-PACIFIC CLINICAL TRIAL MARKET FOR OBESITY TREATMENT

TABLE 5 DISTRIBUTION OF PRODUCTS AND PROJECTS BY PHASE ASIA-PACIFIC OBESITY TREATMENT MARKET

TABLE 6 DISTRIBUTION OF PROJECTS BY THERAPEUTIC AREA AND PHASE ASIA-PACIFIC OBESITY TREATMENT MARKET

TABLE 7 ASIA-PACIFIC OBESITY STATISTICS (2022)

TABLE 8 ASIA-PACIFIC OBESITY TREATMENT MARKET, BY TREATMENT TYPE, 2018-2032 (USD THOUSAND)

TABLE 9 ASIA-PACIFIC PHARMACOLOGICAL TREATMENTS (ANTI-OBESITY DRUGS) IN OBESITY TREATMENT MARKET, BY REGION, 2018-2032 (USD THOUSAND)

TABLE 10 ASIA-PACIFIC PHARMACOLOGICAL TREATMENT (ANTI-OBESITY DRUGS) IN OBESITY TREATMENT MARKET, BY TYPE, 2018-2032 (USD THOUSAND)

TABLE 11 ASIA-PACIFIC CENTRALLY ACTING ANORECTICS IN OBESITY TREATMENT MARKET, BY TYPE, 2018-2032 (USD THOUSAND)

TABLE 12 ASIA-PACIFIC BARIATRIC SURGERY IN OBESITY TREATMENT MARKET, BY REGION, 2018-2032 (USD THOUSAND)

TABLE 13 ASIA-PACIFIC BARIATRIC SURGERY IN OBESITY TREATMENT MARKET, BY TYPE, 2018-2032 (USD THOUSAND)

TABLE 14 ASIA-PACIFIC RESTRICTIVE SURGERIES IN OBESITY TREATMENT MARKET, BY TYPE, 2018-2032 (USD THOUSAND)

TABLE 15 ASIA-PACIFIC COMBINATION SURGERIES IN OBESITY TREATMENT MARKET, BY CLASS, 2018-2032 (USD THOUSAND)

TABLE 16 ASIA-PACIFIC BARIATRIC SURGERY IN OBESITY TREATMENT MARKET, BY APPROACH, 2018-2032 (USD THOUSAND)

TABLE 17 ASIA-PACIFIC BEHAVIORAL & LIFESTYLE THERAPY IN OBESITY TREATMENT MARKET, BY REGION, 2018-2032 (USD THOUSAND)

TABLE 18 ASIA-PACIFIC BEHAVIORAL & LIFESTYLE THERAPY IN OBESITY TREATMENT MARKET, BY TYPE, 2018-2032 (USD THOUSAND)

TABLE 19 ASIA-PACIFIC NON-INVASIVE/ ENDOSCOPIC PROCEDURES IN OBESITY TREATMENT MARKET, BY REGION, 2018-2032 (USD THOUSAND)

TABLE 20 ASIA-PACIFIC NON-INVASIVE/ ENDOSCOPIC PROCEDURES IN OBESITY TREATMENT MARKET, BY TYPE, 2018-2032 (USD THOUSAND)

TABLE 21 ASIA-PACIFIC INTRAGASTRIC BALLOON (IGB) IN OBESITY TREATMENT MARKET, BY TYPE, 2018-2032 (USD THOUSAND)

TABLE 22 ASIA-PACIFIC MEDICAL DEVICES & TECHNOLOGIES IN OBESITY TREATMENT MARKET, BY REGION, 2018-2032 (USD THOUSAND)

TABLE 23 ASIA-PACIFIC MEDICAL DEVICES & TECHNOLOGIES IN OBESITY TREATMENT MARKET, BY TYPE, 2018-2032 (USD THOUSAND)

TABLE 24 ASIA-PACIFIC OBESITY TREATMENT MARKET, BY AGE GROUP, 2018-2032 (USD THOUSAND)

TABLE 25 ASIA-PACIFIC ADULT OBESITY TREATMENT IN OBESITY TREATMENT MARKET, BY REGION, 2018-2032 (USD THOUSAND)

TABLE 26 ASIA-PACIFIC GERIATRIC OBESITY TREATMENT IN OBESITY TREATMENT MARKET, BY REGION, 2018-2032 (USD THOUSAND)

TABLE 27 ASIA-PACIFIC PEDIATRIC OBESITY TREATMENT IN OBESITY TREATMENT MARKET, BY REGION, 2018-2032 (USD THOUSAND)

TABLE 28 ASIA-PACIFIC OBESITY TREATMENT MARKET, BY DISTRIBUTION CHANNEL, 2018-2032 (USD THOUSAND)

TABLE 29 ASIA-PACIFIC ONLINE PHARMACIES IN OBESITY TREATMENT MARKET, BY REGION, 2018-2032 (USD THOUSAND)

TABLE 30 ASIA-PACIFIC RETAIL PHARMACIES IN OBESITY TREATMENT MARKET, BY REGION, 2018-2032 (USD THOUSAND)

TABLE 31 ASIA-PACIFIC WEIGHT MANAGEMENT CLINICS IN OBESITY TREATMENT MARKET, BY REGION, 2018-2032 (USD THOUSAND)

TABLE 32 ASIA-PACIFIC HOSPITAL PHARMACIES IN OBESITY TREATMENT MARKET, BY REGION, 2018-2032 (USD THOUSAND)

TABLE 33 ASIA-PACIFIC WELLNESS & FITNESS CENTERS IN OBESITY TREATMENT MARKET, BY REGION, 2018-2032 (USD THOUSAND)

TABLE 34 ASIA-PACIFIC OBESITY TREATMENT MARKET, BY PATIENT TYPE, 2018-2032 (USD THOUSAND)

TABLE 35 ASIA-PACIFIC CLASS III IN OBESITY TREATMENT MARKET, BY REGION, 2018-2032 (USD THOUSAND)

TABLE 36 ASIA-PACIFIC CLASS II IN OBESITY TREATMENT MARKET, BY REGION, 2018-2032 (USD THOUSAND)

TABLE 37 ASIA-PACIFIC CLASS I IN OBESITY TREATMENT MARKET, BY REGION, 2018-2032 (USD THOUSAND)

TABLE 38 ASIA- PACIFIC OBESITY TREATMENT MARKET, BY COUNTRY, 2018-2032 (USD THOUSAND)

TABLE 39 ASIA- PACIFIC OBESITY TREATMENT MARKET, BY TREATMENT TYPE, 2018-2032 (USD THOUSAND)

TABLE 40 ASIA- PACIFIC PHARMACOLOGICAL TREATMENT (ANTI-OBESITY DRUGS) IN OBESITY TREATMENT MARKET, BY TYPE, 2018-2032 (USD THOUSAND)

TABLE 41 ASIA- PACIFIC CENTRALLY ACTING ANORECTICS IN OBESITY TREATMENT MARKET, BY TYPE, 2018-2032 (USD THOUSAND)

TABLE 42 ASIA- PACIFIC BARIATRIC SURGERY IN OBESITY TREATMENT MARKET, BY TYPE, 2018-2032 (USD THOUSAND)

TABLE 43 ASIA- PACIFIC RESTRICTIVE SURGERIES IN OBESITY TREATMENT MARKET, BY TYPE, 2018-2032 (USD THOUSAND)

TABLE 44 ASIA- PACIFIC COMBINATION SURGERIES IN OBESITY TREATMENT MARKET, BY CLASS, 2018-2032 (USD THOUSAND)

TABLE 45 ASIA- PACIFIC BARIATRIC SURGERY IN OBESITY TREATMENT MARKET, BY APPROACH, 2018-2032 (USD THOUSAND)

TABLE 46 ASIA- PACIFIC BEHAVIORAL & LIFESTYLE THERAPY IN OBESITY TREATMENT MARKET, BY TYPE, 2018-2032 (USD THOUSAND)

TABLE 47 ASIA- PACIFIC NON-INVASIVE/ ENDOSCOPIC PROCEDURES IN OBESITY TREATMENT MARKET, BY TYPE, 2018-2032 (USD THOUSAND)

TABLE 48 ASIA- PACIFIC INTRAGASTRIC BALLOON (IGB) IN OBESITY TREATMENT MARKET, BY TYPE, 2018-2032 (USD THOUSAND)

TABLE 49 ASIA- PACIFIC MEDICAL DEVICES & TECHNOLOGIES IN OBESITY TREATMENT MARKET, BY TYPE, 2018-2032 (USD THOUSAND)

TABLE 50 ASIA- PACIFIC OBESITY TREATMENT MARKET, BY AGE GROUP, 2018-2032 (USD THOUSAND)

TABLE 51 ASIA- PACIFIC OBESITY TREATMENT MARKET, BY DISTRIBUTION CHANNEL, 2018-2032 (USD THOUSAND)

TABLE 52 ASIA- PACIFIC OBESITY TREATMENT MARKET, BY PATIENT TYPE, 2018-2032 (USD THOUSAND)

TABLE 53 CHINA OBESITY TREATMENT MARKET, BY TREATMENT TYPE, 2018-2032 (USD THOUSAND)

TABLE 54 CHINA PHARMACOLOGICAL TREATMENT (ANTI-OBESITY DRUGS) IN OBESITY TREATMENT MARKET, BY TYPE, 2018-2032 (USD THOUSAND)

TABLE 55 CHINA CENTRALLY ACTING ANORECTICS IN OBESITY TREATMENT MARKET, BY TYPE, 2018-2032 (USD THOUSAND)

TABLE 56 CHINA BARIATRIC SURGERY IN OBESITY TREATMENT MARKET, BY TYPE, 2018-2032 (USD THOUSAND)

TABLE 57 CHINA RESTRICTIVE SURGERIES IN OBESITY TREATMENT MARKET, BY TYPE, 2018-2032 (USD THOUSAND)

TABLE 58 CHINA COMBINATION SURGERIES IN OBESITY TREATMENT MARKET, BY CLASS, 2018-2032 (USD THOUSAND)

TABLE 59 CHINA BARIATRIC SURGERY IN OBESITY TREATMENT MARKET, BY APPROACH, 2018-2032 (USD THOUSAND)

TABLE 60 CHINA BEHAVIORAL & LIFESTYLE THERAPY IN OBESITY TREATMENT MARKET, BY TYPE, 2018-2032 (USD THOUSAND)

TABLE 61 CHINA NON-INVASIVE/ ENDOSCOPIC PROCEDURES IN OBESITY TREATMENT MARKET, BY TYPE, 2018-2032 (USD THOUSAND)

TABLE 62 CHINA INTRAGASTRIC BALLOON (IGB) IN OBESITY TREATMENT MARKET, BY TYPE, 2018-2032 (USD THOUSAND)

TABLE 63 CHINA MEDICAL DEVICES & TECHNOLOGIES IN OBESITY TREATMENT MARKET, BY TYPE, 2018-2032 (USD THOUSAND)

TABLE 64 CHINA OBESITY TREATMENT MARKET, BY AGE GROUP, 2018-2032 (USD THOUSAND)

TABLE 65 CHINA OBESITY TREATMENT MARKET, BY DISTRIBUTION CHANNEL, 2018-2032 (USD THOUSAND)

TABLE 66 CHINA OBESITY TREATMENT MARKET, BY PATIENT TYPE, 2018-2032 (USD THOUSAND)

TABLE 67 JAPAN OBESITY TREATMENT MARKET, BY TREATMENT TYPE, 2018-2032 (USD THOUSAND)

TABLE 68 JAPAN PHARMACOLOGICAL TREATMENT (ANTI-OBESITY DRUGS) IN OBESITY TREATMENT MARKET, BY TYPE, 2018-2032 (USD THOUSAND)

TABLE 69 JAPAN CENTRALLY ACTING ANORECTICS IN OBESITY TREATMENT MARKET, BY TYPE, 2018-2032 (USD THOUSAND)

TABLE 70 JAPAN BARIATRIC SURGERY IN OBESITY TREATMENT MARKET, BY TYPE, 2018-2032 (USD THOUSAND)

TABLE 71 JAPAN RESTRICTIVE SURGERIES IN OBESITY TREATMENT MARKET, BY TYPE, 2018-2032 (USD THOUSAND)

TABLE 72 JAPAN COMBINATION SURGERIES IN OBESITY TREATMENT MARKET, BY CLASS, 2018-2032 (USD THOUSAND)

TABLE 73 JAPAN BARIATRIC SURGERY IN OBESITY TREATMENT MARKET, BY APPROACH, 2018-2032 (USD THOUSAND)

TABLE 74 JAPAN BEHAVIORAL & LIFESTYLE THERAPY IN OBESITY TREATMENT MARKET, BY TYPE, 2018-2032 (USD THOUSAND)

TABLE 75 JAPAN NON-INVASIVE/ ENDOSCOPIC PROCEDURES IN OBESITY TREATMENT MARKET, BY TYPE, 2018-2032 (USD THOUSAND)

TABLE 76 JAPAN INTRAGASTRIC BALLOON (IGB) IN OBESITY TREATMENT MARKET, BY TYPE, 2018-2032 (USD THOUSAND)

TABLE 77 JAPAN MEDICAL DEVICES & TECHNOLOGIES IN OBESITY TREATMENT MARKET, BY TYPE, 2018-2032 (USD THOUSAND)

TABLE 78 JAPAN OBESITY TREATMENT MARKET, BY AGE GROUP, 2018-2032 (USD THOUSAND)

TABLE 79 JAPAN OBESITY TREATMENT MARKET, BY DISTRIBUTION CHANNEL, 2018-2032 (USD THOUSAND)

TABLE 80 JAPAN OBESITY TREATMENT MARKET, BY PATIENT TYPE, 2018-2032 (USD THOUSAND)

TABLE 81 INDIA OBESITY TREATMENT MARKET, BY TREATMENT TYPE, 2018-2032 (USD THOUSAND)

TABLE 82 INDIA PHARMACOLOGICAL TREATMENT (ANTI-OBESITY DRUGS) IN OBESITY TREATMENT MARKET, BY TYPE, 2018-2032 (USD THOUSAND)

TABLE 83 INDIA CENTRALLY ACTING ANORECTICS IN OBESITY TREATMENT MARKET, BY TYPE, 2018-2032 (USD THOUSAND)

TABLE 84 INDIA BARIATRIC SURGERY IN OBESITY TREATMENT MARKET, BY TYPE, 2018-2032 (USD THOUSAND)

TABLE 85 INDIA RESTRICTIVE SURGERIES IN OBESITY TREATMENT MARKET, BY TYPE, 2018-2032 (USD THOUSAND)

TABLE 86 INDIA COMBINATION SURGERIES IN OBESITY TREATMENT MARKET, BY CLASS, 2018-2032 (USD THOUSAND)

TABLE 87 INDIA BARIATRIC SURGERY IN OBESITY TREATMENT MARKET, BY APPROACH, 2018-2032 (USD THOUSAND)

TABLE 88 INDIA BEHAVIORAL & LIFESTYLE THERAPY IN OBESITY TREATMENT MARKET, BY TYPE, 2018-2032 (USD THOUSAND)

TABLE 89 INDIA NON-INVASIVE/ ENDOSCOPIC PROCEDURES IN OBESITY TREATMENT MARKET, BY TYPE, 2018-2032 (USD THOUSAND)

TABLE 90 INDIA INTRAGASTRIC BALLOON (IGB) IN OBESITY TREATMENT MARKET, BY TYPE, 2018-2032 (USD THOUSAND)

TABLE 91 INDIA MEDICAL DEVICES & TECHNOLOGIES IN OBESITY TREATMENT MARKET, BY TYPE, 2018-2032 (USD THOUSAND)

TABLE 92 INDIA OBESITY TREATMENT MARKET, BY AGE GROUP, 2018-2032 (USD THOUSAND)

TABLE 93 INDIA OBESITY TREATMENT MARKET, BY DISTRIBUTION CHANNEL, 2018-2032 (USD THOUSAND)

TABLE 94 INDIA OBESITY TREATMENT MARKET, BY PATIENT TYPE, 2018-2032 (USD THOUSAND)

TABLE 95 AUSTRALIA OBESITY TREATMENT MARKET, BY TREATMENT TYPE, 2018-2032 (USD THOUSAND)

TABLE 96 AUSTRALIA PHARMACOLOGICAL TREATMENT (ANTI-OBESITY DRUGS) IN OBESITY TREATMENT MARKET, BY TYPE, 2018-2032 (USD THOUSAND)

TABLE 97 AUSTRALIA CENTRALLY ACTING ANORECTICS IN OBESITY TREATMENT MARKET, BY TYPE, 2018-2032 (USD THOUSAND)

TABLE 98 AUSTRALIA BARIATRIC SURGERY IN OBESITY TREATMENT MARKET, BY TYPE, 2018-2032 (USD THOUSAND)

TABLE 99 AUSTRALIA RESTRICTIVE SURGERIES IN OBESITY TREATMENT MARKET, BY TYPE, 2018-2032 (USD THOUSAND)

TABLE 100 AUSTRALIA COMBINATION SURGERIES IN OBESITY TREATMENT MARKET, BY CLASS, 2018-2032 (USD THOUSAND)

TABLE 101 AUSTRALIA BARIATRIC SURGERY IN OBESITY TREATMENT MARKET, BY APPROACH, 2018-2032 (USD THOUSAND)

TABLE 102 AUSTRALIA BEHAVIORAL & LIFESTYLE THERAPY IN OBESITY TREATMENT MARKET, BY TYPE, 2018-2032 (USD THOUSAND)

TABLE 103 AUSTRALIA NON-INVASIVE/ ENDOSCOPIC PROCEDURES IN OBESITY TREATMENT MARKET, BY TYPE, 2018-2032 (USD THOUSAND)

TABLE 104 AUSTRALIA INTRAGASTRIC BALLOON (IGB) IN OBESITY TREATMENT MARKET, BY TYPE, 2018-2032 (USD THOUSAND)

TABLE 105 AUSTRALIA MEDICAL DEVICES & TECHNOLOGIES IN OBESITY TREATMENT MARKET, BY TYPE, 2018-2032 (USD THOUSAND)

TABLE 106 AUSTRALIA OBESITY TREATMENT MARKET, BY AGE GROUP, 2018-2032 (USD THOUSAND)

TABLE 107 AUSTRALIA OBESITY TREATMENT MARKET, BY DISTRIBUTION CHANNEL, 2018-2032 (USD THOUSAND)

TABLE 108 AUSTRALIA OBESITY TREATMENT MARKET, BY PATIENT TYPE, 2018-2032 (USD THOUSAND)

TABLE 109 SOUTH KOREA OBESITY TREATMENT MARKET, BY TREATMENT TYPE, 2018-2032 (USD THOUSAND)

TABLE 110 SOUTH KOREA PHARMACOLOGICAL TREATMENT (ANTI-OBESITY DRUGS) IN OBESITY TREATMENT MARKET, BY TYPE, 2018-2032 (USD THOUSAND)

TABLE 111 SOUTH KOREA CENTRALLY ACTING ANORECTICS IN OBESITY TREATMENT MARKET, BY TYPE, 2018-2032 (USD THOUSAND)

TABLE 112 SOUTH KOREA BARIATRIC SURGERY IN OBESITY TREATMENT MARKET, BY TYPE, 2018-2032 (USD THOUSAND)

TABLE 113 SOUTH KOREA RESTRICTIVE SURGERIES IN OBESITY TREATMENT MARKET, BY TYPE, 2018-2032 (USD THOUSAND)

TABLE 114 SOUTH KOREA COMBINATION SURGERIES IN OBESITY TREATMENT MARKET, BY CLASS, 2018-2032 (USD THOUSAND)

TABLE 115 SOUTH KOREA BARIATRIC SURGERY IN OBESITY TREATMENT MARKET, BY APPROACH, 2018-2032 (USD THOUSAND)

TABLE 116 SOUTH KOREA BEHAVIORAL & LIFESTYLE THERAPY IN OBESITY TREATMENT MARKET, BY TYPE, 2018-2032 (USD THOUSAND)

TABLE 117 SOUTH KOREA NON-INVASIVE/ ENDOSCOPIC PROCEDURES IN OBESITY TREATMENT MARKET, BY TYPE, 2018-2032 (USD THOUSAND)

TABLE 118 SOUTH KOREA INTRAGASTRIC BALLOON (IGB) IN OBESITY TREATMENT MARKET, BY TYPE, 2018-2032 (USD THOUSAND)

TABLE 119 SOUTH KOREA MEDICAL DEVICES & TECHNOLOGIES IN OBESITY TREATMENT MARKET, BY TYPE, 2018-2032 (USD THOUSAND)

TABLE 120 SOUTH KOREA OBESITY TREATMENT MARKET, BY AGE GROUP, 2018-2032 (USD THOUSAND)

TABLE 121 SOUTH KOREA OBESITY TREATMENT MARKET, BY DISTRIBUTION CHANNEL, 2018-2032 (USD THOUSAND)

TABLE 122 SOUTH KOREA OBESITY TREATMENT MARKET, BY PATIENT TYPE, 2018-2032 (USD THOUSAND)

TABLE 123 TAIWAN OBESITY TREATMENT MARKET, BY TREATMENT TYPE, 2018-2032 (USD THOUSAND)

TABLE 124 TAIWAN PHARMACOLOGICAL TREATMENT (ANTI-OBESITY DRUGS) IN OBESITY TREATMENT MARKET, BY TYPE, 2018-2032 (USD THOUSAND)

TABLE 125 TAIWAN CENTRALLY ACTING ANORECTICS IN OBESITY TREATMENT MARKET, BY TYPE, 2018-2032 (USD THOUSAND)

TABLE 126 TAIWAN BARIATRIC SURGERY IN OBESITY TREATMENT MARKET, BY TYPE, 2018-2032 (USD THOUSAND)

TABLE 127 TAIWAN RESTRICTIVE SURGERIES IN OBESITY TREATMENT MARKET, BY TYPE, 2018-2032 (USD THOUSAND)

TABLE 128 TAIWAN COMBINATION SURGERIES IN OBESITY TREATMENT MARKET, BY CLASS, 2018-2032 (USD THOUSAND)

TABLE 129 TAIWAN BARIATRIC SURGERY IN OBESITY TREATMENT MARKET, BY APPROACH, 2018-2032 (USD THOUSAND)

TABLE 130 TAIWAN BEHAVIORAL & LIFESTYLE THERAPY IN OBESITY TREATMENT MARKET, BY TYPE, 2018-2032 (USD THOUSAND)

TABLE 131 TAIWAN NON-INVASIVE/ ENDOSCOPIC PROCEDURES IN OBESITY TREATMENT MARKET, BY TYPE, 2018-2032 (USD THOUSAND)

TABLE 132 TAIWAN INTRAGASTRIC BALLOON (IGB) IN OBESITY TREATMENT MARKET, BY TYPE, 2018-2032 (USD THOUSAND)

TABLE 133 TAIWAN MEDICAL DEVICES & TECHNOLOGIES IN OBESITY TREATMENT MARKET, BY TYPE, 2018-2032 (USD THOUSAND)

TABLE 134 TAIWAN OBESITY TREATMENT MARKET, BY AGE GROUP, 2018-2032 (USD THOUSAND)

TABLE 135 TAIWAN OBESITY TREATMENT MARKET, BY DISTRIBUTION CHANNEL, 2018-2032 (USD THOUSAND)

TABLE 136 TAIWAN OBESITY TREATMENT MARKET, BY PATIENT TYPE, 2018-2032 (USD THOUSAND)

TABLE 137 SINGAPORE OBESITY TREATMENT MARKET, BY TREATMENT TYPE, 2018-2032 (USD THOUSAND)

TABLE 138 SINGAPORE PHARMACOLOGICAL TREATMENT (ANTI-OBESITY DRUGS) IN OBESITY TREATMENT MARKET, BY TYPE, 2018-2032 (USD THOUSAND)

TABLE 139 SINGAPORE CENTRALLY ACTING ANORECTICS IN OBESITY TREATMENT MARKET, BY TYPE, 2018-2032 (USD THOUSAND)

TABLE 140 SINGAPORE BARIATRIC SURGERY IN OBESITY TREATMENT MARKET, BY TYPE, 2018-2032 (USD THOUSAND)

TABLE 141 SINGAPORE RESTRICTIVE SURGERIES IN OBESITY TREATMENT MARKET, BY TYPE, 2018-2032 (USD THOUSAND)

TABLE 142 SINGAPORE COMBINATION SURGERIES IN OBESITY TREATMENT MARKET, BY CLASS, 2018-2032 (USD THOUSAND)

TABLE 143 SINGAPORE BARIATRIC SURGERY IN OBESITY TREATMENT MARKET, BY APPROACH, 2018-2032 (USD THOUSAND)

TABLE 144 SINGAPORE BEHAVIORAL & LIFESTYLE THERAPY IN OBESITY TREATMENT MARKET, BY TYPE, 2018-2032 (USD THOUSAND)

TABLE 145 SINGAPORE NON-INVASIVE/ ENDOSCOPIC PROCEDURES IN OBESITY TREATMENT MARKET, BY TYPE, 2018-2032 (USD THOUSAND)

TABLE 146 SINGAPORE INTRAGASTRIC BALLOON (IGB) IN OBESITY TREATMENT MARKET, BY TYPE, 2018-2032 (USD THOUSAND)

TABLE 147 SINGAPORE MEDICAL DEVICES & TECHNOLOGIES IN OBESITY TREATMENT MARKET, BY TYPE, 2018-2032 (USD THOUSAND)

TABLE 148 SINGAPORE OBESITY TREATMENT MARKET, BY AGE GROUP, 2018-2032 (USD THOUSAND)

TABLE 149 SINGAPORE OBESITY TREATMENT MARKET, BY DISTRIBUTION CHANNEL, 2018-2032 (USD THOUSAND)

TABLE 150 SINGAPORE OBESITY TREATMENT MARKET, BY PATIENT TYPE, 2018-2032 (USD THOUSAND)

TABLE 151 MALAYSIA OBESITY TREATMENT MARKET, BY TREATMENT TYPE, 2018-2032 (USD THOUSAND)

TABLE 152 MALAYSIA PHARMACOLOGICAL TREATMENT (ANTI-OBESITY DRUGS) IN OBESITY TREATMENT MARKET, BY TYPE, 2018-2032 (USD THOUSAND)

TABLE 153 MALAYSIA CENTRALLY ACTING ANORECTICS IN OBESITY TREATMENT MARKET, BY TYPE, 2018-2032 (USD THOUSAND)

TABLE 154 MALAYSIA BARIATRIC SURGERY IN OBESITY TREATMENT MARKET, BY TYPE, 2018-2032 (USD THOUSAND)

TABLE 155 MALAYSIA RESTRICTIVE SURGERIES IN OBESITY TREATMENT MARKET, BY TYPE, 2018-2032 (USD THOUSAND)

TABLE 156 MALAYSIA COMBINATION SURGERIES IN OBESITY TREATMENT MARKET, BY CLASS, 2018-2032 (USD THOUSAND)

TABLE 157 MALAYSIA BARIATRIC SURGERY IN OBESITY TREATMENT MARKET, BY APPROACH, 2018-2032 (USD THOUSAND)

TABLE 158 MALAYSIA BEHAVIORAL & LIFESTYLE THERAPY IN OBESITY TREATMENT MARKET, BY TYPE, 2018-2032 (USD THOUSAND)

TABLE 159 MALAYSIA NON-INVASIVE/ ENDOSCOPIC PROCEDURES IN OBESITY TREATMENT MARKET, BY TYPE, 2018-2032 (USD THOUSAND)

TABLE 160 MALAYSIA INTRAGASTRIC BALLOON (IGB) IN OBESITY TREATMENT MARKET, BY TYPE, 2018-2032 (USD THOUSAND)

TABLE 161 MALAYSIA MEDICAL DEVICES & TECHNOLOGIES IN OBESITY TREATMENT MARKET, BY TYPE, 2018-2032 (USD THOUSAND)

TABLE 162 MALAYSIA OBESITY TREATMENT MARKET, BY AGE GROUP, 2018-2032 (USD THOUSAND)

TABLE 163 MALAYSIA OBESITY TREATMENT MARKET, BY DISTRIBUTION CHANNEL, 2018-2032 (USD THOUSAND)

TABLE 164 MALAYSIA OBESITY TREATMENT MARKET, BY PATIENT TYPE, 2018-2032 (USD THOUSAND)

TABLE 165 THAILAND OBESITY TREATMENT MARKET, BY TREATMENT TYPE, 2018-2032 (USD THOUSAND)

TABLE 166 THAILAND PHARMACOLOGICAL TREATMENT (ANTI-OBESITY DRUGS) IN OBESITY TREATMENT MARKET, BY TYPE, 2018-2032 (USD THOUSAND)

TABLE 167 THAILAND CENTRALLY ACTING ANORECTICS IN OBESITY TREATMENT MARKET, BY TYPE, 2018-2032 (USD THOUSAND)

TABLE 168 THAILAND BARIATRIC SURGERY IN OBESITY TREATMENT MARKET, BY TYPE, 2018-2032 (USD THOUSAND)

TABLE 169 THAILAND RESTRICTIVE SURGERIES IN OBESITY TREATMENT MARKET, BY TYPE, 2018-2032 (USD THOUSAND)

TABLE 170 THAILAND COMBINATION SURGERIES IN OBESITY TREATMENT MARKET, BY CLASS, 2018-2032 (USD THOUSAND)

TABLE 171 THAILAND BARIATRIC SURGERY IN OBESITY TREATMENT MARKET, BY APPROACH, 2018-2032 (USD THOUSAND)

TABLE 172 THAILAND BEHAVIORAL & LIFESTYLE THERAPY IN OBESITY TREATMENT MARKET, BY TYPE, 2018-2032 (USD THOUSAND)

TABLE 173 THAILAND NON-INVASIVE/ ENDOSCOPIC PROCEDURES IN OBESITY TREATMENT MARKET, BY TYPE, 2018-2032 (USD THOUSAND)

TABLE 174 THAILAND INTRAGASTRIC BALLOON (IGB) IN OBESITY TREATMENT MARKET, BY TYPE, 2018-2032 (USD THOUSAND)

TABLE 175 THAILAND MEDICAL DEVICES & TECHNOLOGIES IN OBESITY TREATMENT MARKET, BY TYPE, 2018-2032 (USD THOUSAND)

TABLE 176 THAILAND OBESITY TREATMENT MARKET, BY AGE GROUP, 2018-2032 (USD THOUSAND)

TABLE 177 THAILAND OBESITY TREATMENT MARKET, BY DISTRIBUTION CHANNEL, 2018-2032 (USD THOUSAND)

TABLE 178 THAILAND OBESITY TREATMENT MARKET, BY PATIENT TYPE, 2018-2032 (USD THOUSAND)

TABLE 179 INDONESIA OBESITY TREATMENT MARKET, BY TREATMENT TYPE, 2018-2032 (USD THOUSAND)

TABLE 180 INDONESIA PHARMACOLOGICAL TREATMENT (ANTI-OBESITY DRUGS) IN OBESITY TREATMENT MARKET, BY TYPE, 2018-2032 (USD THOUSAND)

TABLE 181 INDONESIA CENTRALLY ACTING ANORECTICS IN OBESITY TREATMENT MARKET, BY TYPE, 2018-2032 (USD THOUSAND)

TABLE 182 INDONESIA BARIATRIC SURGERY IN OBESITY TREATMENT MARKET, BY TYPE, 2018-2032 (USD THOUSAND)

TABLE 183 INDONESIA RESTRICTIVE SURGERIES IN OBESITY TREATMENT MARKET, BY TYPE, 2018-2032 (USD THOUSAND)

TABLE 184 INDONESIA COMBINATION SURGERIES IN OBESITY TREATMENT MARKET, BY CLASS, 2018-2032 (USD THOUSAND)

TABLE 185 INDONESIA BARIATRIC SURGERY IN OBESITY TREATMENT MARKET, BY APPROACH, 2018-2032 (USD THOUSAND)

TABLE 186 INDONESIA BEHAVIORAL & LIFESTYLE THERAPY IN OBESITY TREATMENT MARKET, BY TYPE, 2018-2032 (USD THOUSAND)

TABLE 187 INDONESIA NON-INVASIVE/ ENDOSCOPIC PROCEDURES IN OBESITY TREATMENT MARKET, BY TYPE, 2018-2032 (USD THOUSAND)

TABLE 188 INDONESIA INTRAGASTRIC BALLOON (IGB) IN OBESITY TREATMENT MARKET, BY TYPE, 2018-2032 (USD THOUSAND)

TABLE 189 INDONESIA MEDICAL DEVICES & TECHNOLOGIES IN OBESITY TREATMENT MARKET, BY TYPE, 2018-2032 (USD THOUSAND)

TABLE 190 INDONESIA OBESITY TREATMENT MARKET, BY AGE GROUP, 2018-2032 (USD THOUSAND)

TABLE 191 INDONESIA OBESITY TREATMENT MARKET, BY DISTRIBUTION CHANNEL, 2018-2032 (USD THOUSAND)

TABLE 192 INDONESIA OBESITY TREATMENT MARKET, BY PATIENT TYPE, 2018-2032 (USD THOUSAND)

TABLE 193 PHILIPPINES OBESITY TREATMENT MARKET, BY TREATMENT TYPE, 2018-2032 (USD THOUSAND)

TABLE 194 PHILIPPINES PHARMACOLOGICAL TREATMENT (ANTI-OBESITY DRUGS) IN OBESITY TREATMENT MARKET, BY TYPE, 2018-2032 (USD THOUSAND)

TABLE 195 PHILIPPINES CENTRALLY ACTING ANORECTICS IN OBESITY TREATMENT MARKET, BY TYPE, 2018-2032 (USD THOUSAND)

TABLE 196 PHILIPPINES BARIATRIC SURGERY IN OBESITY TREATMENT MARKET, BY TYPE, 2018-2032 (USD THOUSAND)

TABLE 197 PHILIPPINES RESTRICTIVE SURGERIES IN OBESITY TREATMENT MARKET, BY TYPE, 2018-2032 (USD THOUSAND)

TABLE 198 PHILIPPINES COMBINATION SURGERIES IN OBESITY TREATMENT MARKET, BY CLASS, 2018-2032 (USD THOUSAND)

TABLE 199 PHILIPPINES BARIATRIC SURGERY IN OBESITY TREATMENT MARKET, BY APPROACH, 2018-2032 (USD THOUSAND)

TABLE 200 PHILIPPINES BEHAVIORAL & LIFESTYLE THERAPY IN OBESITY TREATMENT MARKET, BY TYPE, 2018-2032 (USD THOUSAND)

TABLE 201 PHILIPPINES NON-INVASIVE/ ENDOSCOPIC PROCEDURES IN OBESITY TREATMENT MARKET, BY TYPE, 2018-2032 (USD THOUSAND)

TABLE 202 PHILIPPINES INTRAGASTRIC BALLOON (IGB) IN OBESITY TREATMENT MARKET, BY TYPE, 2018-2032 (USD THOUSAND)

TABLE 203 PHILIPPINES MEDICAL DEVICES & TECHNOLOGIES IN OBESITY TREATMENT MARKET, BY TYPE, 2018-2032 (USD THOUSAND)

TABLE 204 PHILIPPINES OBESITY TREATMENT MARKET, BY AGE GROUP, 2018-2032 (USD THOUSAND)

TABLE 205 PHILIPPINES OBESITY TREATMENT MARKET, BY DISTRIBUTION CHANNEL, 2018-2032 (USD THOUSAND)

TABLE 206 PHILIPPINES OBESITY TREATMENT MARKET, BY PATIENT TYPE, 2018-2032 (USD THOUSAND)

TABLE 207 VIETNAM OBESITY TREATMENT MARKET, BY TREATMENT TYPE, 2018-2032 (USD THOUSAND)

TABLE 208 VIETNAM PHARMACOLOGICAL TREATMENT (ANTI-OBESITY DRUGS) IN OBESITY TREATMENT MARKET, BY TYPE, 2018-2032 (USD THOUSAND)

TABLE 209 VIETNAM CENTRALLY ACTING ANORECTICS IN OBESITY TREATMENT MARKET, BY TYPE, 2018-2032 (USD THOUSAND)

TABLE 210 VIETNAM BARIATRIC SURGERY IN OBESITY TREATMENT MARKET, BY TYPE, 2018-2032 (USD THOUSAND)

TABLE 211 VIETNAM RESTRICTIVE SURGERIES IN OBESITY TREATMENT MARKET, BY TYPE, 2018-2032 (USD THOUSAND)

TABLE 212 VIETNAM COMBINATION SURGERIES IN OBESITY TREATMENT MARKET, BY CLASS, 2018-2032 (USD THOUSAND)

TABLE 213 VIETNAM BARIATRIC SURGERY IN OBESITY TREATMENT MARKET, BY APPROACH, 2018-2032 (USD THOUSAND)

TABLE 214 VIETNAM BEHAVIORAL & LIFESTYLE THERAPY IN OBESITY TREATMENT MARKET, BY TYPE, 2018-2032 (USD THOUSAND)

TABLE 215 VIETNAM NON-INVASIVE/ ENDOSCOPIC PROCEDURES IN OBESITY TREATMENT MARKET, BY TYPE, 2018-2032 (USD THOUSAND)

TABLE 216 VIETNAM INTRAGASTRIC BALLOON (IGB) IN OBESITY TREATMENT MARKET, BY TYPE, 2018-2032 (USD THOUSAND)

TABLE 217 VIETNAM MEDICAL DEVICES & TECHNOLOGIES IN OBESITY TREATMENT MARKET, BY TYPE, 2018-2032 (USD THOUSAND)

TABLE 218 VIETNAM OBESITY TREATMENT MARKET, BY AGE GROUP, 2018-2032 (USD THOUSAND)

TABLE 219 VIETNAM OBESITY TREATMENT MARKET, BY DISTRIBUTION CHANNEL, 2018-2032 (USD THOUSAND)

TABLE 220 VIETNAM OBESITY TREATMENT MARKET, BY PATIENT TYPE, 2018-2032 (USD THOUSAND)

TABLE 221 REST OF ASIA-PACIFIC OBESITY TREATMENT MARKET, BY TREATMENT TYPE, 2018-2032 (USD THOUSAND)

图片列表

FIGURE 1 ASIA-PACIFIC OBESITY TREATMENT MARKET: SEGMENTATION

FIGURE 2 ASIA-PACIFIC OBESITY TREATMENT MARKET: DATA TRIANGULATION

FIGURE 3 ASIA-PACIFIC OBESITY TREATMENT MARKET: DROC ANALYSIS

FIGURE 4 ASIA-PACIFIC OBESITY TREATMENT MARKET: REGIONAL MARKET ANALYSIS

FIGURE 5 ASIA-PACIFIC OBESITY TREATMENT MARKET: COMPANY RESEARCH ANALYSIS

FIGURE 6 ASIA-PACIFIC OBESITY TREATMENT MARKET: LIFELINE CURVE

FIGURE 7 ASIA-PACIFIC OBESITY TREATMENT MARKET: INTERVIEW DEMOGRAPHICS

FIGURE 8 ASIA-PACIFIC OBESITY TREATMENT MARKET: DBMR MARKET POSITION GRID

FIGURE 9 ASIA-PACIFIC OBESITY TREATMENT MARKET: MARKET END USER COVERAGE GRID

FIGURE 10 ASIA-PACIFIC OBESITY TREATMENT MARKET: VENDOR SHARE ANALYSIS

FIGURE 11 ASIA-PACIFIC OBESITY TREATMENT MARKET: SEGMENTATION

FIGURE 12 ASIA-PACIFIC OBESITY TREATMENT MARKET EXECUTIVE SUMMARY

FIGURE 13 STRATEGIC DECISIONS

FIGURE 14 FIVE SEGMENTS COMPRISE THE ASIA-PACIFIC OBESITY TREATMENT MARKET , BY TREATMENT TYPE

FIGURE 15 RISING PREVALENCE OF OBESITY IS EXPECTED TO DRIVE THE GROWTH OF ASIA-PACIFIC OBESITY TREATMENT MARKET FROM 2025 TO 2032

FIGURE 16 THE PHARMACOLOGICAL TREATMENTS (ANTI-OBESITY DRUGS) SEGMENT IS EXPECTED TO ACCOUNT FOR THE LARGEST SHARE OF THE ASIA-PACIFIC OBESITY TREATMENT MARKET IN 2025 - 2032

FIGURE 17 MARKET OVERVIEW

FIGURE 18 PREVALENCE OF OBESITY IN ADULTS AGE 20 AND OLDER, BY SEX AND AGE: UNITED STATES, AUGUST 2021–AUGUST 2023 SOURCE: CENTERS FOR DISEASE CONTROL AND PREVENTION.

FIGURE 19 SHARE OF PRE-OBESE AND OBESE PERSONS AGED 16 YEARS OR OVER, BY SEX, 2022 (%)

FIGURE 20 ASIA-PACIFIC OBESITY TREATMENT MARKET: BY TREATMENT TYPE, 2024

FIGURE 21 ASIA-PACIFIC OBESITY TREATMENT MARKET: BY TREATMENT TYPE, 2025-2032 (USD THOUSAND)

FIGURE 22 ASIA-PACIFIC OBESITY TREATMENT MARKET: BY TREATMENT TYPE, CAGR (2025-2032)

FIGURE 23 ASIA-PACIFIC OBESITY TREATMENT MARKET: BY TREATMENT TYPE, LIFELINE CURVE

FIGURE 24 ASIA-PACIFIC OBESITY TREATMENT MARKET: BY AGE GROUP, 2024

FIGURE 25 ASIA-PACIFIC OBESITY TREATMENT MARKET: BY AGE GROUP, 2025-2032 (USD THOUSAND)

FIGURE 26 ASIA-PACIFIC OBESITY TREATMENT MARKET: BY AGE GROUP, CAGR (2025-2032)

FIGURE 27 ASIA-PACIFIC OBESITY TREATMENT MARKET: BY AGE GROUP, LIFELINE CURVE

FIGURE 28 ASIA-PACIFIC OBESITY TREATMENT MARKET: BY DISTRIBUTION CHANNEL, 2024

FIGURE 29 ASIA-PACIFIC OBESITY TREATMENT MARKET: BY DISTRIBUTION CHANNEL, 2025-2032 (USD THOUSAND)

FIGURE 30 ASIA-PACIFIC OBESITY TREATMENT MARKET: BY DISTRIBUTION CHANNEL, CAGR (2025-2032)

FIGURE 31 ASIA-PACIFIC OBESITY TREATMENT MARKET: BY DISTRIBUTION CHANNEL, LIFELINE CURVE

FIGURE 32 ASIA-PACIFIC OBESITY TREATMENT MARKET: BY PATIENT TYPE, 2024

FIGURE 33 ASIA-PACIFIC OBESITY TREATMENT MARKET: BY PATIENT TYPE, 2025-2032 (USD THOUSAND)

FIGURE 34 ASIA-PACIFIC OBESITY TREATMENT MARKET: BY PATIENT TYPE, CAGR (2025-2032)

FIGURE 35 ASIA-PACIFIC OBESITY TREATMENT MARKET: BY PATIENT TYPE, LIFELINE CURVE

FIGURE 36 ASIA-PACIFIC OBESITY TREATMENT MARKET: SNAPSHOT (2024)

FIGURE 37 ASIA-PACIFIC OBESITY TREATMENT MARKET: COMPANY SHARE 2024 (%)

查看详细信息

研究方法

数据收集和基准年分析是使用具有大样本量的数据收集模块完成的。该阶段包括通过各种来源和策略获取市场信息或相关数据。它包括提前检查和规划从过去获得的所有数据。它同样包括检查不同信息源中出现的信息不一致。使用市场统计和连贯模型分析和估计市场数据。此外，市场份额分析和关键趋势分析是市场报告中的主要成功因素。要了解更多信息，请请求分析师致电或下拉您的询问。

DBMR 研究团队使用的关键研究方法是数据三角测量，其中包括数据挖掘、数据变量对市场影响的分析和主要（行业专家）验证。数据模型包括供应商定位网格、市场时间线分析、市场概览和指南、公司定位网格、专利分析、定价分析、公司市场份额分析、测量标准、全球与区域和供应商份额分析。要了解有关研究方法的更多信息，请向我们的行业专家咨询。

可定制

Data Bridge Market Research 是高级形成性研究领域的领导者。我们为向现有和新客户提供符合其目标的数据和分析而感到自豪。报告可定制，包括目标品牌的价格趋势分析、了解其他国家的市场（索取国家列表）、临床试验结果数据、文献综述、翻新市场和产品基础分析。目标竞争对手的市场分析可以从基于技术的分析到市场组合策略进行分析。我们可以按照您所需的格式和数据样式添加您需要的任意数量的竞争对手数据。我们的分析师团队还可以为您提供原始 Excel 文件数据透视表（事实手册）中的数据，或者可以帮助您根据报告中的数据集创建演示文稿。

Frequently Asked Questions

《亞太肥胖治療市場》报告涵盖的主要细分市场是什么？

市场是基于亞太地區肥胖治療市場細分，按治療類型（藥物治療（抗肥胖藥物）、減肥手術、行為與生活方式療法、非侵入性/內視鏡手術以及醫療器械與技術）、年齡組（成人肥胖治療、老年肥胖治療和兒童肥胖治療）、分銷渠道（在線藥房、零售藥店、體重管理診所、醫院藥房和健康與健身中心）、患者類型 2020 2023 階段 -II 20 II 類进行细分的。

当前亞太肥胖治療市場的市场规模是多少？

在2024年，亞太肥胖治療市場的规模估计为5.09 USD Million美元。

预计亞太肥胖治療市場的增长率是多少？

亞太肥胖治療市場预计将在2025年至2032年的预测期内以CAGR 16%的速度增长。

谁是亞太肥胖治療市場的主要参与者？

市场上的主要参与者包括Boston Scientific Corporation (U.S.) ,Johnson & Johnson Services Inc. (U.S.) ,Altimmune (U.S.) ,AstraZeneca (UK) ,Allurion (U.S.) ,Amgen Inc. (U.S.)。

亞太肥胖治療市場規模、份額及趨勢分析報告－產業概況及2032年預測

通过敏捷供应链咨询解决关税挑战

Asia Pacific Obesity Treatment Market

CAGR : 16.00 %

亞太肥胖治療市場規模

亞太肥胖症治療市場分析

報告範圍和肥胖治療市場細分

亞太肥胖治療市場關鍵市場洞察

亞太肥胖症治療市場趨勢

亞太肥胖症治療市場動態

亞太肥胖治療市場範圍

亞太肥胖治療市場區域分析

亞太肥胖症治療市佔率

亞太肥胖治療市場的最新發展

Get online access to the report on the World's First Market Intelligence Cloud

目录

表格列表

图片列表

研究方法

可定制

Frequently Asked Questions

报告

市场洞察

支持

解决方案

亞太肥胖治療市場規模、份額及趨勢分析報告－產業概況及2032年預測

通过敏捷供应链咨询解决关税挑战

Asia Pacific Obesity Treatment Market

CAGR : 16.00 %

亞太肥胖治療市場規模

亞太肥胖症治療市場分析

報告範圍和肥胖治療市場細分

亞太肥胖治療市場關鍵市場洞察

亞太肥胖症治療市場趨勢

亞太肥胖症治療市場動態

亞太肥胖治療市場範圍

亞太肥胖治療市場區域分析

亞太肥胖症治療市佔率

亞太肥胖治療市場的最新發展

Get online access to the report on the World's First Market Intelligence Cloud

目录

表格列表

图片列表

研究方法

可定制

Frequently Asked Questions

浏览相关页面